- Home
- JPC vs NEO Comparison
JPC vs NEO Comparison
Compare JPC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JPC
- NEO
- Stock Information
- Founded
- JPC 2003
- NEO 2001
- Country
- JPC United States
- NEO United States
- Employees
- JPC N/A
- NEO N/A
- Industry
- JPC Investment Managers
- NEO Precision Instruments
- Sector
- JPC Finance
- NEO Health Care
- Exchange
- JPC Nasdaq
- NEO Nasdaq
- Market Cap
- JPC 2.6B
- NEO 2.1B
- IPO Year
- JPC N/A
- NEO 1999
- Fundamental
- Price
- JPC $8.06
- NEO $15.04
- Analyst Decision
- JPC
- NEO Strong Buy
- Analyst Count
- JPC 0
- NEO 9
- Target Price
- JPC N/A
- NEO $19.89
- AVG Volume (30 Days)
- JPC 998.5K
- NEO 792.3K
- Earning Date
- JPC 01-01-0001
- NEO 11-05-2024
- Dividend Yield
- JPC 7.57%
- NEO N/A
- EPS Growth
- JPC N/A
- NEO N/A
- EPS
- JPC N/A
- NEO N/A
- Revenue
- JPC N/A
- NEO $644,118,000.00
- Revenue This Year
- JPC N/A
- NEO $12.93
- Revenue Next Year
- JPC N/A
- NEO $9.70
- P/E Ratio
- JPC N/A
- NEO N/A
- Revenue Growth
- JPC N/A
- NEO 12.06
- 52 Week Low
- JPC $5.94
- NEO $12.77
- 52 Week High
- JPC $7.36
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- JPC 45.71
- NEO 52.58
- Support Level
- JPC $8.03
- NEO $13.35
- Resistance Level
- JPC $8.12
- NEO $16.60
- Average True Range (ATR)
- JPC 0.07
- NEO 0.67
- MACD
- JPC -0.00
- NEO 0.18
- Stochastic Oscillator
- JPC 30.00
- NEO 53.98
About JPC Nuveen Preferred & Income Opportunities Fund
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.